Shenghui Integration's Indonesian subsidiary has secured a significant construction project valued at approximately 223 million RMB. This project involves the development of a shoe sole and footwear production facility. Separately, a subsidiary of Sunshine Nuohe has received approval for clinical trials for its STC009 injection, intended for treating secondary hyperparathyroidism. AI
影响 This cluster reports on a construction project win and a drug trial approval, with no direct impact on AI operators.
排序理由 The cluster contains news about subsidiaries winning contracts and receiving regulatory approval for drug trials, which are not frontier AI releases or significant industry-wide events.
- Chengdu Nuohe Shengtai Biotechnology Co., Ltd.
- National Medical Products Administration
- PT ACTER INTEGRATION TECHNOLOGY INDONESIA
- PT. Hardases Abadi Indonesia
- Shenghui Integration
- STC009 injection
- Sunshine Nuohe
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →